The forecast for leukemia mortality among females in the US suggests a gradual increase from 2024 to 2028. Starting at 9.97 thousand deaths in 2024, the figures are projected to rise to 10.19 thousand by 2028. Compared to a stable mortality rate in 2023, the increments represent modest year-on-year growth. Despite this upward trend, the compound annual growth rate (CAGR) from 2024 to 2028 is anticipated to remain low, indicating sustained but slow-paced growth over the years.
Future trends to monitor include advancements in medical treatments and early detection, which could potentially decelerate mortality growth. Additionally, demographic shifts and healthcare policy developments may also impact these projections.
